In the News

Feb 22, 2022 Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum and V-Smart® Platform are highlighted in Discussion Group Report, “Prominent Names in RNA Delivery Discuss What’s Around the Corner”, by Tom Cohen of Oxford Global.
Jan 19, 2021 Lauren Sciences discussed on the Ozy site here.
Sep 17, 2020 Lauren Sciences discussed on the FightMND site here. and again here.
Jul 7, 2020 Lauren Sciences discussed in “Update on glioma biotechnology”, Boockvar JA et al., Clin Neurol Neurosurg. 2020 Jul 7;195:106075.
Feb 11, 2020 Lauren Sciences CEO Susan Rosenbaum was interviewed by Proactive Investors at BIO CEO & Investor Conference in New York on February 11, 2020. Lauren Sciences is privately-held New York-based biotechnology company developing V-Smart® Nanomedicines to treat brain diseases. Last year it was announced that Lauren Sciences was awarded AU $1M translational grant by Australian-based FightMND. See interview, “Lauren Sciences wins 4th grant for its ALS drug”
Jun 2, 2019 Lauren Sciences Won 1st Place at China Focus Global Healthcare Innovation Competition during BIO 2019 in Philadelphia, PA.
Apr 4, 2019 ALS News Today article on FightMND Awards Grant to Lauren Sciences to Develop Promising ALS Therapy.
Mar 1, 2019 $7.6m committed to new research projects during 2019 - FightMND
Mar 1, 2019 Neal Daniher's FightMND delivers seven new research projects - Herald Sun
Jul 25, 2018 BIO, biotechnology industry’s leading organization, announces Lauren Sciences as one of the winners at forum held during BIO’s 25th International Convention in June in Boston, MA.
Apr 18, 2018 Lauren Sciences Awarded Third Grant for Development of Potential ALS Therapeutic - The ALS Association Blog
Apr 11, 2018 Lauren Sciences LLC Awarded Grant from The ALS Association - AABGU
Mar 12, 2018 Lauren Sciences "V-Smart®: A Breakthrough Innovation" is cover feature of March 2018 issue of Drug Development & Delivery magazine. Article entitled, “V-Smart® Nanomedicines: Non-Invasive Targeted Brain Therapeutics for CNS Diseases”, is authored by Susan Rosenbaum, J.D. and Irwin Hollander, Ph.D.
Dec 1, 2017 The official blog of the ALS association on the highlights from the annual Society for Neuroscience meeting in Washington, D.C.
Jul 26, 2017Easier Way to Deliver Parkinson’s Medication - AABGU
Aug 8, 2015Campbell Foundation Funding: We See Results | Funding AIDS/HIV research | Fort Lauderdale| The Campbell Foundation
Jul 22, 2015 Labroots - Crossing the Blood Brain Barrier
Jul 2, 2015 V-Smart® Technology Could Be the Answer to Brain Tumor Treatment - AABGU
May 5, 2015 The ALS Association I Progress in Drug Development Reviewed at The ALS Association Drug Company Working Group Meeting
May 7, 2014Nano Drug Delivery for Parkinson’s - AABGU
May 5, 2014Vesicles Can Cross Blood Brain Barrier to Treat Central Nervous System Disorders - The Bio Science Technology
Jul 31, 2012BGU Scientists Overcome ‘Blood Brain Barrier’ - The Jerusalem Post
Apr 11, 2012 New Hope for Parkinson’s and Other Central Nervous System Disease Sufferers - AABGU
Apr 10, 2012Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm